A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: The Rancho Bernardo study

European Journal of Endocrinology

Volumn 151, Issue 6, 2004, Pages 717-725

  Tannenbaum, Cara ^c   Barrett Connor, Elizabeth ^a   Laughlin, Gail A ^a   Platt, Robert W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGED; AGING; ANDROGEN BLOOD LEVEL; ARTICLE; ARTIFACT; BODY WEIGHT; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING; UNITED STATES;

AGED; AGING; ALGORITHMS; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 11844284790     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510717     Document Type: Article

References (53)

1. Labrie F. Intracrinology, Molecular Cell Endocrinology 1991 78 C113-C118.
2. Labrie F, Belanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez JL & Candas B. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids 1998 63 322-328.
3. Hornsby PJ. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Annals of the New York Academy of Science 1995 774 29-46.
4. Laurie F, Belanger A, Cuban L & Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. Journal of Clinical Endocrinology and Metabolism 1997 82 2392-2402.
5. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D & von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2000 85 645-651.
6. Orentreich N, Brind JL, Rizer RL & Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulphate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 1984 59 551-555.
7. Orentreich N, Brind JL, Vogelman JH, Andres R & Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. Journal of Clinical Endocrinology and Metabolism 1992 75 1002-1004.
8. Kahonen MH, Tilvis RS, Jokkonen J, Pitkala K & Harkonen M. Predictors and clinical significance of declining plasma dehydroepiandrosterone sulfate in old age. Journal of Aging, Clinical and Experimental Research 2000 12 308-314.
9. Mazat L, Lafont S, Berr C, Debuire B, Tessier JF, Dartigues JF & Baulieu EE. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits and 10-year mortality. PNAS 2001 98 8145-8150.
10. Campbell DT & Kenny DA. A Primer on Regression Artifacts New York: Guilford Press, 1999.
11. Streiner DL. Regression toward the mean: its etiology, diagnosis and treatment. Canadian Journal of Psychiatry 2001 46 72-76.
12. Trochim W. The Research Methods Knowledge Base, 2nd edn. Cincinnati, Ohio: Atomic Dog Publishing, 2000.
13. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Journal of Epidemiology 1976 104 493-498.
14. Shepard DS & Finison LJ. Blood pressure reductions: correcting for regression to the mean. Preventive Medicine 1983 12 304-317.
15. Tilvis RS, Kahonen M & Harkonen M. Dehydroepiandrosterone sulphate, diseases and mortality in a general aged population. Aging (Milano) 1999 11 30-34.
16. Barrett-Connor E & Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Annals of the New York Academy of Science 1995 774 259-270.
17. Newcomer LM, Manson JE, Barbieri RL, Hennekins CH & Stampfer MJ. Dehydroepiandrosterone sulphate and the risk of myocardial infarction in US male physicians: a prospective study. American Journal of Epidemiology 1994 140 870-875.
18. Feldman HA, Johannes C, McKinlay JB & Longcope C. Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study. American Journal of Epidemiology 1998 8 217-228.
19. Johannes CB, Stellato RK, Feldman HA, Longcope C & McKinlay JB. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: longitudinal results from the Massachusetts Women's Health Study. Journal of Clinical Epidemiology 1999 52 95-103.
20. Trivedi DP & Khaw KT. Dehydroepiandrosterone sulphate and mortality in elderly men and women. Journal of Clinical Endocrinology and Metabolism 2001 86 4171-4177.
21. Herrington DM. Dehydroepiandrosterone and coronary atherosclerosis. Annals of the New York Academy of Science 1995 774 271-280.
22. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B & Baulieu E. Dehydroepiandrosterone sulphate in a long-term care aged population. Gerontology 1995 41 343-351.
23. Berr C, Lafont S, Debuire B, Dartigues JF & Baulieu EE. Relationships of dehydroepiandrosterone-sulfate in the elderly with functional, psychological, and mental status, and short-term mortality; a French community-based study. PNAS 1996 93 13410-13415.
24. Moffat SD, Zonderman AB, Harman SM, Blackman MR, Kawas C & Resnick SM. The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men. Archives of Internal Medicine 2000 160 2193-2198.
25. Cuckle H, Stone R, Smith D, Wald N, Brammer M, Hajimohammedreza I, Levy R, Chard T & Perry L. Dehydroepiandrosterone sulphate in Alzheimer's disease. Lancet 1990 336 449-450.
26. Barrett-Connor E & Edelstein SL. A prospective study of dehydroepiandrosterone sulfate and cognitive function in an older population: the Rancho Bernardo Study. Journal of the American Geriatrics Society 1994 42 420-423.
27. Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C & Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biological Psychiatry 1998 43 694-700.
28. Vallee M, Mayo W & Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Brain Research Reviews 2001 37 301-312.
29. Ravaglia R, Forti P, Maioli F, Sacchetti L, Nativio V, Scali CR, Mariani E, Zanardi V, Stefanini S & Macini PL. Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population. Experimental Gerontology 2002 37 701-712.
30. Greendale GA, Edelstein S & Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. Journal of Bone and Mineral Research 1997 12 1833-1843.
31. Clarke BL, Ebeling PR, Jones JD, Wahner HW, O'Fallon WM, Riggs BL & Fitzpatrick LA. Predictors of bone mineral density in aging healthy men varies by skeletal site. Calcified Tissue International 2002 70 137-145.
32. Barrett-Connor E, Kritz-Silverstein D & Edelstein SL. A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. American Journal of Epidemiology 1993 137 201-206.
33. Barrett-Connor E, von Muhlen D, Laughlin GA & Kripke A. Endogenous levels of dehydroepiandrosterone sulphate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo Study. Journal of the American Geriatrics Society 1999 47 685-691.
34. Ebeling P & Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994 343 1479-1481.
35. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute 2002 94 606-616.
36. Le Bail JC, Lotfi H, Charles L, Pepin D & Habrioux G. Conversion of dehydroepiandrosterone sulfate at physiological plasma concentration into estrogens in MCF-7 cells. Steroids 2002 67 1057-1064.
37. Helzlsouer KJ, Gordon GB, Alberg A, Bush TL & Comstock GW Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Research 1992 52 1-4.
38. Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE & Debuire B. Serum dehydroepiandrosterone sulphate levels as an individual marker. Journal of Clinical Endocrinology and Metabolism 1994 79 1273-1276.
39. Muti P, Trevisan M, Michell A, Krogh V, Bolelli G, Sciajno R & Berrino F. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiology Biomarkers and Prevention 1996 5 917-922.
40. Laughlin GA & Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2000 85 3561-3568.
41. Nafziger AN, Bowlin SJ, Jenkins PL & Pearson TA. Longitudinal changes in dehydroepiandrosterone concentrations in men and women. Journal of Laboratory and Clinical Medicine 1998 131 316-323.
42. Barrett-Connor E & Goodman-Gruen D. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women: the Rancho Bernardo Study. Circulation 1995 91 1757-1760.
43. Parker CR, Mixon RL, Brissie RM & Grizzle WE. Aging alters zonation in the adrenal cortex of men. Journal of Clinical Endocrinology and Metabolism 1997 82 3898-3901.
44. Hornsby PJ. Aging of the human adrenal cortex. Ageing Research Reviews 2002 1 229-242.
45. Rotter JI, Wong L, Lifrak ET & Parker IN. A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism 1985 34 731-736.
46. An P, Rosmond R, Borecki IB, Ukkola O, Rice T, Gagnon J, Rankinen T, Leon AS, Skinner JS, Wilmore JH, Bouchard C & Rao DC. Genome-wide linkage scan to detect loci influencing levels of dehydroepiandrosterones in the HERITAGE Family Study. Metabolism 2001 50 1315-1322.
47. Legro RS, Kunselman AR, Demers L, Wang SC, Bentley-Lewis R & Dunaif A. Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 2134-2138.
48. Rice T, Sprecher DL, Borecki IB, Mitchell LE, Laskarzewski PM & Rao DC. The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families. Metabolism 1993 42 1284-1290.
49. Jakubowicz DJ, Beer NA, Beer RM & Nestler JE. Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women. Journal of Clinical Endocrinology and Metabolism 1995 80 3373-3376.
50. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history of fasting hyperglycemia. American Journal of Epidemiology 1980 111 705-712.
51. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C & Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2 - 3 year period. Cancer Epidemiology Biomarkers and Prevention 1995 4 649-654.
52. Kley RK, Schlaghecke R & Kruskemper HL. Stability of steroids in plasma over a 10 year period. Journal of Clinical Chemistry and Clinical Biochemistry 1985 23 875-878.
53. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, Pisani P & Berrino F. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiology Biomarkers and Prevention 1995 4 509-513.